At a crossroads, California’s stem cell agency ponders a future without taxpayer support - The Washington Post: California’s stem cell agency wielded the extraordinary power to dole out $3 billion in bond proceeds to fund embryonic stem cell work with an eye toward treatments for a host of crippling diseases. Midway through its mission, with several high-tech labs constructed, but little to show on the medicine front beyond basic research, the California Institute for Regenerative Medicine faces an uncertain future.
'via Blog this'
No comments:
Post a Comment